| Released | Contributor | Author | Title | Pages | Price |
| 10-Dec-2009 | New Constructs, LLC |
N/A
| EMIS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 10-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 10-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
| 9-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 7-Dec-2009 | Reuters Investment Profile |
N/A
| Emisphere Technologies Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 5-Dec-2009 | Standard & Poor's Quantitative Report |
N/A
| Emisphere Technologies | 5 |
$25 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | EMISPHERE TECHNOLOGIES INC (EMIS=US) 2-weeks forecast | 1 |
$10 |
| 4-Dec-2009 | Pechala's Reports | Frantisek Pechala | EMISPHERE TECHNOLOGIES INC (EMIS=US) 12-months forecast | 1 |
$15 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: EMISPHERE TECH -- EMIS | 1 |
$4 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: EMIS , MBRX , SPPI -- DRUGS | 3 |
$4 |
0.67% Nasdaq 
Research Reports
